Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

ELISA Kit Testing Methods: Principles, Protocols, Sample Requirements, and Applications

ELISA (Enzyme-Linked Immunosorbent Assay) kit testing methods provide a sensitive, specific, and high-throughput immunochemical platform for detecting and quantifying analytes such as cytokines, hormones, antibodies, tumor markers, and infectious disease antigens in biological samples. This technical article systematically describes the principles, sample types, assay formats, standard operating procedures, validation parameters, and application scenarios of ELISA kit testing in clinical diagnostic and research laboratories.

Technical Overview

ELISA (Enzyme-Linked Immunosorbent Assay) is a plate-based immunological technique that uses antigen-antibody binding specificity coupled with enzyme-mediated colorimetric detection to measure the concentration of a target analyte in a liquid sample. The analyte is captured either on a solid phase (typically a 96-well or 384-well polystyrene microplate) by immobilized antibodies or antigens, and the binding event is visualized through an enzyme conjugate—most commonly horseradish peroxidase (HRP) or alkaline phosphatase (ALP)—acting on a chromogenic substrate such as TMB (3,3',5,5'-tetramethylbenzidine). The resulting color intensity, measured by a microplate spectrophotometer at 450 nm (with 570–630 nm wavelength correction), is proportional or inversely proportional to the analyte concentration, which is interpolated from a calibration curve generated with certified reference standards.

A complete ELISA kit typically contains the following components: a pre-coated microplate (or capture antibody plus coating buffer for self-coating formats), multi-level calibrated standards, quality control samples, biotinylated or enzyme-conjugated detection antibodies, streptavidin-HRP conjugate (where applicable), sample and assay diluents, concentrated wash buffer (PBS or TBS with Tween-20), chromogenic substrate solution, stop solution (typically 1–2 M sulfuric acid), and adhesive plate sealers. Well-designed kits are validated against recognized frameworks such as ICH M10 for bioanalytical method validation, ISO 13485 for medical device quality management, and CLSI evaluation protocols for clinical immunoassay performance.

ELISA offers several technical advantages: detection limits in the pg/mL to ng/mL range, compatibility with a large number of sample matrices, amenability to automation via liquid-handling robots and plate washers, relatively low cost per test, and good intra-assay and inter-assay reproducibility when validated coefficients of variation are maintained, typically below 10% and 15% respectively.

Testing Samples

Serum

Serum is the most common matrix for ELISA testing. Whole blood is collected using serum separator tubes or plain tubes, allowed to clot at room temperature for 30–60 minutes, and centrifuged at 1,000–2,000 × g for 10–15 minutes. Hemolyzed, lipemic, or repeatedly frozen-thawed samples should be avoided because endogenous peroxidase activity, particulate lipids, and analyte degradation can introduce analytical interference. Serum samples are typically stable at 2–8 °C for up to 5 days and at −20 °C or −80 °C for longer storage.

Plasma

Plasma is obtained by collecting whole blood into anticoagulant tubes containing EDTA, heparin, or sodium citrate, followed by centrifugation within 30 minutes of collection. The choice of anticoagulant must be compatible with the specific kit; EDTA plasma is widely suitable, whereas heparin and citrate may interfere in certain cytokine or coagulation-related assays. Platelet-poor plasma (additional centrifugation at 10,000 × g) is recommended when measuring platelet-derived analytes such as PDGF or PF4.

Cell Culture Supernatant

Conditioned media from stimulated or unstimulated cell cultures are centrifuged at 300–500 × g for 5–10 minutes to remove cells and debris, then assayed directly or after dilution. Serum-containing media may generate background in some assays, so matrix-matched standards or media blanks should be included when high sensitivity is required.

Tissue and Cell Lysates

Tissues are homogenized in ice-cold PBS or RIPA-type lysis buffer supplemented with protease inhibitors, centrifuged at 10,000 × g for 10 minutes at 4 °C, and the clarified supernatant is collected. Total protein concentration should be determined (for example by BCA or Bradford assay) so that the target analyte can be normalized and reported per milligram of total protein. Excessive detergent concentrations above the kit-specified tolerance should be avoided.

Uine and Other Body Fluids

Urine, cerebrospinal fluid, saliva, synovial fluid, bronchoalveolar lavage fluid, and milk can also be analyzed, subject to matrix validation. Urine samples should generally be centrifuged and may require normalization to creatinine. Matrix effects such as hook effect at extreme concentrations or heterophilic antibody interference should be assessed during method suitability evaluation.

Testing Items

ELISA kits are applied to a broad analyte spectrum spanning clinical diagnostics, life science research, and industrial quality control. Representative testing items include:

  • Cytokines and chemokines: IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17, TNF-α, IFN-γ, GM-CSF, MCP-1, and related inflammatory mediators.
  • Hormones and endocrine markers: cortisol, insulin, T3/T4, TSH, estradiol, progesterone, testosterone, growth hormone, and leptin.
  • Infectious disease markers: IgM/IgG antibodies against viruses and bacteria, viral surface and core antigens, and seroconversion monitoring targets.
  • Tumor markers: CEA, AFP, PSA, CA-125, CA-19-9, CYFRA 21-1, and HE4.
  • Cardiac and metabolic markers: troponin I/T, CK-MB, myoglobin, BNP, adiponectin, and oxidized LDL.
  • Immunology and autoimmunity markers: immunoglobulins (IgE, IgG subclasses), rheumatoid factor, anti-dsDNA, and complement components.
  • Signal molecules and proteins: cAMP, cGMP, nitric oxide metabolites, apoptosis regulators, phosphorylated proteins, and receptor ligands.
  • Food safety and veterinary residues: mycotoxins (aflatoxin B1, ochratoxin A, vomitoxin), veterinary drug residues, hormones in animal products, and allergen proteins.
  • Biopharmaceutical analysis: host cell proteins, residual Protein A, anti-drug antibodies for immunogenicity assessment, and pharmacokinetic quantification of biologics.

Testing Methods

Sandwich ELISA

The sandwich format is the most widely used method for larger analytes with multiple epitopes. A capture antibody immobilized on the microplate binds the analyte in standards and samples. After washing, a detection antibody binds a second epitope, forming a capture–analyte–detection sandwich. An enzyme conjugate (for example streptavidin-HRP binding a biotinylated detection antibody) is added, unbound material is washed away, and TMB substrate develops a color whose intensity is directly proportional to analyte concentration. Sandwich ELISA provides high specificity because two independent antibodies must bind the target simultaneously.

Competitive ELISA

The competitive format is preferred for small molecules, haptens, and analytes with a single epitope. Sample analyte competes with a fixed amount of enzyme-labeled or immobilized analyte for a limited number of antibody binding sites. The measured signal is inversely proportional to the analyte concentration in the sample. This format is common for steroid hormones, mycotoxins, and drug residues.

Direct ELISA

In direct ELISA, the antigen is immobilized directly on the plate and detected with an enzyme-labeled primary antibody. The protocol is short and involves fewer cross-reactions, but sensitivity is generally lower and each target requires a separately labeled antibody.

Indirect ELISA

In indirect ELISA, the immobilized antigen is detected by an unlabeled primary antibody followed by an enzyme-labeled secondary antibody. This two-step detection amplifies the signal and allows one labeled secondary reagent to serve many primary antibodies, which is why the format is widely used for antibody titer determination and serological screening.

Standard Operating Procedure

A typical quantitative sandwich ELISA protocol follows these steps:

  • Equilibrate all reagents, standards, and samples to room temperature (20–25 °C) and prepare working solutions of wash buffer, standards, and detection reagents.
  • Prepare a serial dilution of the standard across at least 6–7 concentration levels to bracket the expected sample concentrations, plus a zero standard (blank).
  • Add standards, controls, and samples to designated wells in duplicate or triplicate, cover the plate, and incubate for the specified time (commonly 60–120 minutes) at 37 °C.
  • Aspirate each well completely and wash 3–5 times with the working wash buffer, ensuring residual liquid is removed by blotting the plate on absorbent paper.
  • Add the detection antibody (and subsequently the HRP conjugate in two-step protocols), incubate, and repeat the washing cycle.
  • Add TMB substrate, protect from light, and incubate for 10–20 minutes until color develops proportionally to concentration.
  • Add stop solution; the color changes from blue to yellow. Read the absorbance at 450 nm within 5–15 minutes using a reference wavelength of 570 nm or 630 nm.
  • Generate a 4-parameter logistic (4PL) or 5-parameter logistic (5PL) standard curve using dedicated software and interpolate sample concentrations; multiply by the dilution factor and verify results fall within the quantifiable range.

Method Validation and Quality Control

Reliable ELISA testing requires documented validation of the following parameters, consistent with ICH M10, ISO 13485 quality system requirements, and applicable clinical laboratory standards:

  • Sensitivity: limit of blank (LoB), limit of detection (LoD), and lower limit of quantification (LLOQ).
  • Accuracy: spike-recovery testing within 80–120% and dilutional linearity across parallel diluted samples.
  • Precision: intra-assay CV (within one plate) generally ≤10%, and inter-assay CV (across plates, operators, days) generally ≤15%.
  • Specificity: assessment of cross-reactivity with structurally related molecules and interference from hemoglobin, lipids, bilirubin, rheumatoid factor, and heterophilic antibodies.
  • Hook effect evaluation: testing high-concentration samples for falsely low results due to antigen excess.
  • Stability: reagent shelf life, sample freeze-thaw tolerance, and post-preparation stability of working solutions.
  • Batch QC: each run must include calibrated standards and low/high QC samples; acceptance criteria for back-calculated standards (typically within ±15%, ±20% at LLOQ) and QC recovery should be predefined in the laboratory's quality documents.

Troubleshooting Common Issues

  • High background across all wells: insufficient washing, contamination, excessive conjugate concentration, or over-development of substrate.
  • Weak or no signal: degraded reagents or standards, incorrect incubation temperature, incomplete reagent equilibration, or analyte below LLOQ.
  • Poor standard curve fit: pipetting error, edge effects from temperature gradients, uneven evaporation, or improper curve model selection.
  • Poor replicate precision: inaccurate pipetting, incompletely aspirated wash buffer, or bubbles in wells prior to reading.

Applications

ELISA kit testing methods serve diverse sectors:

  • Clinical diagnostics: quantification of infectious disease antibodies and antigens, tumor marker monitoring, endocrine and fertility workups, allergy testing (specific IgE), and autoimmune disease screening in accredited medical laboratories.
  • Pharmaceutical and biopharmaceutical development: pharmacokinetic and pharmacodynamic bioanalysis of biologics, immunogenicity (anti-drug antibody) testing, host cell protein and residual impurity quantification, and potency release testing aligned with ICH quality guidelines.
  • Vaccine research and development: measurement of vaccine-induced antibody titers, neutralizing antibody surrogates, and cytokine release profiles during preclinical and clinical evaluation.
  • Academic and translational research: biomarker discovery and validation, immunology mechanism studies, signal transduction assays, and multi-analyte profiling of inflammation, apoptosis, and metabolism pathways.
  • Food safety and agriculture: screening of mycotoxins, veterinary drug residues, illegal additives, GMO proteins, and allergens in raw materials and finished products, often as a high-throughput screening step before confirmatory chromatographic or mass spectrometric analysis.
  • Environmental and veterinary monitoring: detection of environmental pollutants, toxins in water and soil extracts, and pathogen surveillance in livestock and poultry populations.

FAQ

How long does a typical ELISA test take?

A standard quantitative sandwich ELISA requires approximately 2.5 to 4.5 hours from reagent equilibration to plate reading, depending on the number of incubation and washing steps. Some fast-format kits using optimized antibodies and elevated incubation temperatures can be completed in 60–90 minutes.

Why is the plate read at 450 nm?

TMB substrate oxidized by HRP in the presence of hydrogen peroxide yields a yellow product after acidification with stop solution, whose maximal absorbance peak is at 450 nm. Dual-wavelength reading with a 570 nm or 630 nm reference corrects for optical imperfections, fingerprints, and turbidity in the well.

What are typical acceptance criteria for a valid run?

Standard operating procedures typically require that the standard curve covers the expected sample range, back-calculated standard concentrations fall within ±15% (±20% at the LLOQ), QC samples meet predefined recovery limits, and replicate CVs do not exceed 10–15%. A run failing these criteria should be repeated after root-cause investigation.

How should kits and samples be stored?

Unopened kits are stored at 2–8 °C protected from light, typically with a shelf life of 6–12 months from the manufacture date. Reconstituted standards should be aliquoted and stored frozen to avoid repeated freeze-thaw cycles. Samples are kept at 2–8 °C for short-term handling and at −20 °C to −80 °C for long-term storage, avoiding more than two freeze-thaw cycles.

What is the hook effect and how is it managed?

The hook effect (prozone effect) occurs when extremely high analyte concentrations saturate capture and detection antibodies simultaneously, producing falsely low readings. Laboratories manage it by analyzing samples at multiple dilutions, incorporating high-level QC checks, and flagging results inconsistent with clinical context for repeat diluted testing.

Can one kit be used across different sample matrices?

Only if matrix compatibility has been demonstrated. Salient differences in protein content, pH, anticoagulants, and endogenous interferents can alter antibody binding kinetics. Laboratories should perform spike-recovery and parallelism studies in each new matrix before reporting results, or use matrix-matched calibration standards.

Why Choose ZKGX?

  • State-of-the-art analytical equipment
  • Highly qualified scientific team
  • Fast turnaround time
  • Competitive pricing